The store will not work correctly when cookies are disabled.
2-(3-(3-Methylbut-2-enyl)-1,4-dioxo-1,4-dihydronaphthalen-2-yloxy)acetonitrile
ID: ALA4436314
PubChem CID: 155511925
Max Phase: Preclinical
Molecular Formula: C17H15NO3
Molecular Weight: 281.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)=CCC1=C(OCC#N)C(=O)c2ccccc2C1=O
Standard InChI: InChI=1S/C17H15NO3/c1-11(2)7-8-14-15(19)12-5-3-4-6-13(12)16(20)17(14)21-10-9-18/h3-7H,8,10H2,1-2H3
Standard InChI Key: QYTVZEWKTOBXBC-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
1.4402 -9.9332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4391 -10.7605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1539 -11.1734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1520 -9.5204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8674 -9.9295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8663 -10.7580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5792 -11.1710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2979 -10.7600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2990 -9.9315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5815 -9.5140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5815 -8.6890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5769 -11.9959 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0112 -11.1745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0145 -9.5208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7279 -9.9350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4434 -9.5242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1588 -9.1134 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7268 -10.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4401 -11.1784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1557 -10.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4377 -12.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
7 12 2 0
8 13 1 0
9 14 1 0
14 15 1 0
15 16 1 0
16 17 3 0
13 18 1 0
18 19 2 0
19 20 1 0
19 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 281.31 | Molecular Weight (Monoisotopic): 281.1052 | AlogP: 3.22 | #Rotatable Bonds: 4 |
Polar Surface Area: 67.16 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.24 | CX LogD: 2.24 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.79 | Np Likeness Score: 0.73 |
References
1. Calil FA, David JS, Chiappetta ERC, Fumagalli F, Mello RB, Leite FHA, Castilho MS, Emery FS, Nonato MC.. (2019) Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase., 167 [PMID:30776695] [10.1016/j.ejmech.2019.02.018] |